Mark McKinlay, PhD, is director for the Center for Vaccine Equity (CVE), a program of The Task Force for Global Health. In this role, Dr. McKinlay oversees The Task Force’s work to increase access to vaccines for cholera and influenza in developing countries. He also guides The Task Force’s work to help eradicate polio. Prior to joining The Task Force, Dr. McKinlay co-founded two pharmaceutical companies where he focused on the development of novel medicines to treat cancer and the common cold.
Samantha Kluglein, Deputy Director of the Center for Vaccine Equity, is responsible for operations management of the Center. Samantha has been with the Center since its inception in 2011 in roles of progressive responsibility contributing to the overall growth and development of the Center. She works with the Director, Program Directors, and external partners to develop, manage and implement the Center’s programs with a focus on the development and management of collaborative partnerships, working groups and initiative specific task forces. Her responsibilities include contributions to strategic planning, program development and implementation, grants administration and stakeholder management.
Alan R. Hinman, MD, is Consulting Advisor for the Center for Vaccine Equity (CVE), a program of The Task Force for Global Health. In this role, Dr. Hinman focuses on expanding access to vaccines to prevent diseases such as polio, cholera, and influenza in developing countries. Prior to joining The Task Force, Dr. Hinman worked at the Centers for Disease Control and Prevention for 30 years and attained the rank of assistant surgeon general.
Joseph (Joe) serves as Director of the Partnership for Influenza Vaccine Introduction. He has more than twenty years of experience working in influenza and vaccines, having started his public health career at the CDC as an EIS officer in the Influenza Branch in 1993. From 1995 to 2005, Joe worked at CDC on viral diseases, with a focus on research and public health activities related to rotavirus disease and rotavirus vaccines to help ensure that rotavirus vaccines were available for children in both the U.S. as well as those living in developing countries. From 2005 – 2017, Joe led the Epidemiology and Prevention Branch of the CDC’s Influenza Division. The Branch is responsible for conducting influenza surveillance, working to understand influenza disease burden, helping to derive appropriate vaccine and antiviral use policies to prevent seasonal influenza, detecting and preventing avian influenza and pandemic influenza, and providing technical expertise to global public health partners.
Dr. John W. Ward is a Senior Scientist at the US CDC assigned to The Task Force for Global Health where he is guiding development of the Program for Viral Hepatitis Elimination. Over a 13-year tenure as Director, Division of Viral Hepatitis, Dr. Ward was responsible for viral hepatitis surveillance, prevention, and research.
Andréa Berlin serves as Project Support Specialist supporting CVE. She has 14 years’ experience coordinating conferences, meetings and continuing education programs, working in non-profit, academic and corporate settings. Her background also includes Public Relations and Marketing along with Training and Development.
In her role as Program Associate, Andréa will work with CVE leadership to coordinate and carry out programmatic activities and events related to the Center’s vaccine programs. She will handle all logistics associated with meetings such as participant travel, facilities/venue management, coordination of technical requirements, and act as a liaison to domestic and international partners.
Amanda Bolster serves as Associate Director of Development and Partnerships at The Task Force for Global Health. As a member of the Center for Vaccine Equity program team, she focuses on engaging new partners in the innovative work of the Partnership for Influenza Vaccine Introduction (PIVI).
With 20 years of branding/communications experience in the nonprofit and corporate sectors, Amanda brings a unique perspective and skill set to the PIVI and Task Force team. Amanda’s work is to cultivate the creative, strategic and impactful partnerships needed to create systems-change at the community, country, and ultimately global level – keeping us all safer from pandemic and other emerging disease threats.
Malembe Ebama, DrPH, joined the Center for Vaccine Equity (CVE) in 2016, serving as Epidemiologist for the Partnership for Influenza Vaccine Introduction (PIVI) program. In her role, she works in partnership with Centers for Disease Control, to engage and provide technical support to low- and middle-income countries implementing or expanding influenza vaccine programs.
Prior to joining the Task Force, Malembe worked for three years as an Epidemiologist for the Georgia Department of Public Health, Office of HIV/AIDS Programs. In her role, she served as the HIV Prevention Data Manager and Project Lead for the Georgia Perinatal HIV Prevention initiative: Georgia FIMR-HIV.
Dr. Hadler joined the Center for Vaccine Equity in April 2018 as a Senior Advisor for Vaccine Preventable Diseases. Previously, he worked for over 40 years in public health at the Centers for Disease Control and Prevention and World Health Organization, with primary focus on prevention and control of vaccine preventable diseases (VPDs), viral hepatitis and bacterial respiratory diseases.
Dominique Richardson serves as the Project Manager supporting the Partnership for Influenza Vaccine Introduction (PIVI) within CVE. She has 7 years of experience in operations and project management in the clinic/hospital setting and worked most recently as a Clinic Operations Manager in Dermatology at the Emory Clinic.
In her third year at the Task Force for Global Health, Chantal Veira shifted her focus from blindness prevention to Polio Eradication when she joined the Center for Vaccine Equity (CVE). She serves as Project Team Lead/Senior Manager within CVE.
Previously, Chantal was Project Manager for the Immunization Management Group (IMG) Support Team. Chantal played a key role in managing the IMG global project plan and the Task Force’s contributions to the introduction of inactivated polio vaccine and in the coordination of polio vaccine switch activities in 146 countries. In further support of the global polio eradication effort, she coordinated the efforts of more than 100 authors in the publication of a Journal of Infectious Diseases supplement that documented and disseminated lessons learned from the polio endgame effort.
Sarah Wanyoike, MPH, is a Public Health Technical Specialist with the Center for Vaccine Equity (CVE) at The Task Force for Global Health. Sarah provides technical support for the Transition Management Group of the Global Polio Eradication Initiative (GPEI). She works with country planning task teams to develop and disseminate guidance for transition planning, support countries (e.g. Ethiopia, Sudan, South Sudan, Angola, and others) in mapping their polio program human and physical resources, and coordinate with country and regional teams in planning for workshops.